DECA P 150MG AQUILA PHARMACEUTICALS

£59.00

DECA P 150MG AQUILA PHARMACEUTICALS provides pharmaceutical-grade nandrolone phenylpropionate for in-vitro research applications. This laboratory research compound enables comprehensive steroid receptor binding studies and molecular pathway investigations.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
DECA P 150MG AQUILA PHARMACEUTICALS
DECA P 150MG AQUILA PHARMACEUTICALS
£59.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Research Overview: DECA P 150MG AQUILA PHARMACEUTICALS

DECA P 150MG AQUILA PHARMACEUTICALS is a research-grade nandrolone phenylpropionate formulation specifically manufactured for laboratory investigation purposes. This pharmaceutical preparation contains 150mg/ml of nandrolone phenylpropionate, enabling researchers to examine anabolic-androgenic steroid mechanisms, receptor binding affinity studies, and cellular protein synthesis pathways. The compound’s shorter ester chain compared to nandrolone decanoate provides researchers with more frequent dosing intervals for controlled experimental protocols. Scientists investigating steroid biochemistry will find this formulation particularly valuable for studying androgen receptor activation and downstream signalling cascades.

Laboratory Investigation Applications

Research scientists utilise DECA P 150MG to investigate various molecular mechanisms within controlled laboratory environments. Primary research applications include examining protein synthesis enhancement pathways, nitrogen retention mechanisms, and collagen synthesis stimulation in cellular models. The compound enables researchers to study anabolic effects on muscle tissue cultures and investigate potential therapeutic applications for muscle wasting conditions. Additionally, investigators can analyse the compound’s interaction with progesterone receptors and evaluate its impact on IGF-1 expression in laboratory settings. Researchers at Stroid UK Shop have access to comprehensive analytical protocols for studying this compound alongside other research chemicals from our nandrolone phenylpropionate collection. Comparative studies with SARMs research compounds and peptide formulations provide valuable insights into selective tissue targeting mechanisms.

Product Specifications

DECA P 150MG Technical Specifications
Active Compound Nandrolone Phenylpropionate
Concentration 150mg/ml
Manufacturer Aquila Pharmaceuticals
Formulation Injectable Solution
CAS Number 62-90-8
Molecular Formula C27H34O3
Storage Room Temperature
Purity Pharmaceutical Grade

Research Compliance Statement

This product is manufactured exclusively for in-vitro laboratory research purposes and is not intended for human consumption, therapeutic use, or any form of in-vivo application. Researchers must maintain appropriate laboratory protocols and safety measures when handling this compound. All investigations should be conducted within properly equipped research facilities by qualified personnel.

Related